Immunohistochemical detection of bcl‐2 protein in liver lesions: bcl‐2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia

Publisher Website
Google Scholar
Abstract
A proto‐oncogene, bcl‐2, encodes a protein that inhibits programmed cell death (apoptosis) and may play a role in cell and tissue differentiation. As bcl‐2 appears to be involved in the turn‐over of stem or precursor cells, it is thought to be operational in carcinogenesis pathways. However, apart from certain lymphomas, only limited data are available on the frequency of its expression in solid tumors. Immunohistochemical analysis with an antibody specific for bcl‐2 protein was used to detect the protein in hepatocellular carcinomas and in one of the putative precursor lesions, liver cell dysplasia. We detected bcl‐2 protein in 5 of 37 hepatocellular carcinomas. Immunoreactivity was not related to type, grade, or extent of PCNA staining of the tumours. No bcl‐2 protein staining was observed in three types of liver cell dysplasia. Thus, bcl‐2 is abnormally expressed in some hepatocellular carcinomas but not in potential tumour precursor cells.